Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.63p
   
  • Change Today:
    -0.13p
  • 52 Week High: 8.35p
  • 52 Week Low: 1.38p
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 260,167
  • Market Cap: £3.94m
  • RiskGrade: 429
  • Beta: 0.01

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 1.63p
Change Today -0.13p
% Change -7.14 %
52 Week High 8.35p
52 Week Low 1.38p
Volume 260,167
Shares Issued 242.54m
Market Cap £3.94m
Beta 0.01
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.69% below the market average11.69% below the market average11.69% below the market average11.69% below the market average11.69% below the market average
4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average
Price Trend
94.52% below the market average94.52% below the market average94.52% below the market average94.52% below the market average94.52% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 29-Apr-2025

Time Volume / Share Price
15:45 208 @ 1.52p
15:37 12,500 @ 1.70p
12:01 5,882 @ 1.70p
11:57 5,882 @ 1.70p
11:55 5,882 @ 1.70p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page